2016
DOI: 10.1016/j.currproblcancer.2015.10.004
|View full text |Cite
|
Sign up to set email alerts
|

From concept to clinic: Mathematically informed immunotherapy

Abstract: To allow innovative, progressive treatments to make the transition from concept to clinic, experimentally calibrated and clinically motivated mathematical models are essential. To aid the development of well-informed clinical trials, collaboration between mathematicians, computational modelers, biologists, and clinicians is required to allow qualitative hypotheses to take on a quantitative dimension. Such interdisciplinary science can allow both personalization and optimization of dose and scheduling of immuno… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 42 publications
(24 citation statements)
references
References 107 publications
0
24
0
Order By: Relevance
“…These results are promising, but further studies need to be done to demonstrate effectiveness in humans. Mathematical modelling has been demonstrated useful to predict patientspecific responses to treatment (such as anti-angiogenic therapy, chemotherapy, radiotherapy and immunotherapy) and suggest novel therapeutic avenues against cancer [176,[193][194][195][196][197][198][199][200][201][202][203][204][205][206][207][208][209]. In the future, appropriate mathematical models should be considered to optimize treatment plans and help to identify causes underlying glioma treatment resistance.…”
Section: Resultsmentioning
confidence: 99%
“…These results are promising, but further studies need to be done to demonstrate effectiveness in humans. Mathematical modelling has been demonstrated useful to predict patientspecific responses to treatment (such as anti-angiogenic therapy, chemotherapy, radiotherapy and immunotherapy) and suggest novel therapeutic avenues against cancer [176,[193][194][195][196][197][198][199][200][201][202][203][204][205][206][207][208][209]. In the future, appropriate mathematical models should be considered to optimize treatment plans and help to identify causes underlying glioma treatment resistance.…”
Section: Resultsmentioning
confidence: 99%
“…In conclusion, we have for the first time applied mathematical modeling as a tool to depict the relative strength of a host's immune response after it has been subjected to a lung tumor vaccine. Here, we showed and can infer that if a synthetic epitope is not between 8-11 aa long, which can be substantiated by the TANTIGEN database, a host will produce an immune response, but that is not ideal to the elimination of cancer [26,27]. Studies are ongoing to elucidate the above perspectives by mathematical modeling through different means.…”
Section: Resultsmentioning
confidence: 99%
“…These tumors were the first where immunotherapy was shown to be successful. Immunotherapy, informed by mathematical modeling, may have a greater chance of leading to durable remissions [52]. …”
Section: Compelling Research Questions In (Cancer) Stem Cell Researchmentioning
confidence: 99%